These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7516147)

  • 21. Parvovirus particles as platforms for protein presentation.
    Miyamura K; Kajigaya S; Momoeda M; Smith-Gill SJ; Young NS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8507-11. PubMed ID: 8078912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation.
    Kawase M; Momoeda M; Young NS; Kajigaya S
    J Virol; 1995 Oct; 69(10):6567-71. PubMed ID: 7666560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.
    Zuffi E; Manaresi E; Gallinella G; Gentilomi GA; Venturoli S; Zerbini M; Musiani M
    Viral Immunol; 2001; 14(2):151-8. PubMed ID: 11398810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.
    Musiani M; Manaresi E; Gallinella G; Venturoli S; Zuffi E; Zerbini M
    J Med Virol; 2000 Mar; 60(3):347-52. PubMed ID: 10630969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
    Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
    J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.
    Bloom ME; Martin DA; Oie KL; Huhtanen ME; Costello F; Wolfinbarger JB; Hayes SF; Agbandje-McKenna M
    J Virol; 1997 Jan; 71(1):705-14. PubMed ID: 8985402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
    Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
    J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine parvovirus capsid assembly and differences in mammalian and insect cells.
    Yuan W; Parrish CR
    Virology; 2001 Jan; 279(2):546-57. PubMed ID: 11162810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
    Corcoran A; Doyle S; Waldron D; Nicholson A; Mahon BP
    J Virol; 2000 Nov; 74(21):9903-10. PubMed ID: 11024117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
    Corcoran A; Mahon BP; Doyle S
    J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assaying for structural variation in the parvovirus capsid and its role in infection.
    Weichert WS; Parker JS; Wahid AT; Chang SF; Meier E; Parrish CR
    Virology; 1998 Oct; 250(1):106-17. PubMed ID: 9770425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
    Ros C; Gerber M; Kempf C
    J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.
    Yoshimoto K; Rosenfeld S; Frickhofen N; Kennedy D; Hills R; Kajigaya S; Young NS
    J Virol; 1991 Dec; 65(12):7056-60. PubMed ID: 1719240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-specific and cross-reactive antigenicity of capsid proteins VP1 and VP2 of echovirus type 7.
    Hasegawa A; Inouye S
    Microbiol Immunol; 1983; 27(10):869-76. PubMed ID: 6199652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
    Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
    Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.
    Mani B; Baltzer C; Valle N; Almendral JM; Kempf C; Ros C
    J Virol; 2006 Jan; 80(2):1015-24. PubMed ID: 16379002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
    Uhlig H; Haardt F; Dernick R
    Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.
    Cotmore SF; D'abramo AM; Ticknor CM; Tattersall P
    Virology; 1999 Feb; 254(1):169-81. PubMed ID: 9927584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.